Targeted Therapies in Cancer
Publisher: Nova Publishers
Published: 2014
Place of publication: USA
ISBN-13: 9781633216761
Table of contents: title: Table of Contents:; title: Preface; title: Chapter 1. Innnovation in the Biopharmaceutical Pipeline; title: Chapter 2. The Diversity of Targeted Cancer Drugs Recently Approved by the FDA; title: Chapter 3. Chronological List of Targeted Cancer Drugs Approved by the FDA; title: Chapter 4. Targeted Cancer Drugs: Detailed Description; title: Chapter 5. Targeted Therapy for Chronic Lymphocytic Leukemia (CLL); title: Chapter 6. Targeted Therapy for HER-2-Positive Breast Cancer; title: Chapter 7. Targeted Therapy for Metastatic Breast Cancer - Varia; title: Chapter 8. Targeted Therapy for Chronic Myelogenous Leukemia (CML); title: Chapter 9. Targeted Therapy for Gastrointestinal Stromal Tumors (GIST); title: Chapter 10. Targeted Therapy for Metastatic Colorectal Cancer (mCRC); title: Chapter 11. Targeted Therapy for Metastatic Melanoma (McM); title: Chapter 12. Targeted Therapy for Multiple Myeloma (MM); title: Chapter 13. Targeted Therapy for Metastatic Castration-Resistant Prostate Cancer (mCRPC); title: Chapter 14. Targeted Therapy for Metastatic Renal Cell Carcinoma (mRCC); title: Chapter 15. Targeted Therapy for Gastric Cancer; title: Chapter 16. Targeted Therapy for Non-Small Cell Lung Cancer (NSCLC); title: Chapter 17. Targeted Therapy for Myelodysplastic Syndromes (MDS); title: Chapter 18. Targeted Therapy for Mantle Cell Lymphoma (MCL); title: Chapter 19. Abbreviations; title: Chapter 20. Generic Names – Trade Names: Equivalences; title: Index